These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11941650)
1. [Publication bias in the clinical drug research]. Keränen T; Ylitalo P Duodecim; 1999; 115(17):1828-32. PubMed ID: 11941650 [No Abstract] [Full Text] [Related]
2. Bias in the design, interpretation, and publication of industry-sponsored clinical research. Hammerschmidt D Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022 [No Abstract] [Full Text] [Related]
3. Control of data, authorship, and responsibility for clinical trials publications. Freeman WR Ophthalmology; 2005 Sep; 112(9):1485-6. PubMed ID: 16139664 [No Abstract] [Full Text] [Related]
4. The publication process itself was the major cause of publication bias in genetic epidemiology. Calnan M; Smith GD; Sterne JA J Clin Epidemiol; 2006 Dec; 59(12):1312-8. PubMed ID: 17098574 [TBL] [Abstract][Full Text] [Related]
5. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
6. Small study on industry trial sponsorship leads to big questions about quality and bias. Twombly R J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566 [No Abstract] [Full Text] [Related]
8. Publication of full reports of clinical trials. Mann H J Clin Oncol; 2003 Nov; 21(22):4254-5. PubMed ID: 14615461 [No Abstract] [Full Text] [Related]
9. Systematic reviews of trials and other studies. Sutton AJ; Abrams KR; Jones DR; Sheldon TA; Song F Health Technol Assess; 1998; 2(19):1-276. PubMed ID: 10347832 [No Abstract] [Full Text] [Related]
10. [Constraints on publication rights in industry-initiated clinical trials--secondary publication]. Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372 [TBL] [Abstract][Full Text] [Related]
12. Drug research. Legislators propose a registry to track clinical trials from start to finish. Couzin J Science; 2004 Sep; 305(5691):1695. PubMed ID: 15375239 [No Abstract] [Full Text] [Related]
13. In the dark: drug companies should be forced to publish all the results of clinical trials. Chalmers I New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350 [No Abstract] [Full Text] [Related]
14. [Minimizing bias in publication of clinical trials]. Chalmers TC Med Clin (Barc); 1992 Feb; 98(8):305-7. PubMed ID: 1560719 [No Abstract] [Full Text] [Related]
15. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Peppercorn J; Blood E; Winer E; Partridge A Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054 [TBL] [Abstract][Full Text] [Related]
16. Implications of pharmaceutical industry funding on clinical research. Lexchin JR Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137 [TBL] [Abstract][Full Text] [Related]
17. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases? Liyanage SS; Raina Macintyre C Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128 [TBL] [Abstract][Full Text] [Related]
18. Tackling publication bias and selective reporting in health informatics research: register your eHealth trials in the International eHealth Studies Registry. Eysenbach G J Med Internet Res; 2004 Sep; 6(3):e35. PubMed ID: 15471761 [TBL] [Abstract][Full Text] [Related]
19. The old file-drawer problem. Kennedy D Science; 2004 Jul; 305(5683):451. PubMed ID: 15273363 [No Abstract] [Full Text] [Related]